WallStSmart
LGVN

Longeveron LLC

NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY

$0.85
-1.74% today

Updated 2026-04-30

Market cap
$26.35M
P/E ratio
P/S ratio
21.98x
EPS (TTM)
$-1.29
Dividend yield
52W range
$0 – $2
Volume
6.9M

Longeveron LLC (LGVN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-1.8%
Last 4 quarters
Revenue YoY growth
-39.5%
Most recent quarter
EPS YoY growth
+18.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+5.9%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+15.6%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.22+40.0%$0.96$1.11+15.6%
2025-11-12$-0.39-50.0%$0.72$0.69-3.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.37$-0.22+40.0%$365000.00-39.5%
2025-09-30$-0.26$-0.39-50.0%$137000.00-82.3%
2025-06-30$-0.35$-0.33+5.7%$316000.00-32.5%
2025-03-31$-0.33$-0.34-3.0%$381000.00-30.5%
2024-12-31$-0.20$-0.27-35.0%$603000.00+857.1%
2024-09-30$-0.44$-0.34+22.7%$773000.00+415.3%
2024-06-30$-0.87$-1.83-110.3%$468000.00+115.7%
2024-03-31$-2.00$-1.61+19.5%$548000.00+130.3%
2023-12-31$-0.21$-0.25-19.0%$63000.00
2023-09-30$-0.22$-0.28-27.3%$150000.00
2023-06-30$-0.25$-0.27-8.0%$217000.00
2023-03-31$-0.21$-0.22-4.8%$238000.00

Frequently asked questions

Has Longeveron LLC beaten earnings estimates?
Longeveron LLC has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -1.8% over the last 4 quarters.
How does LGVN stock react to earnings?
LGVN stock has moved an average of +5.9% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Longeveron LLC's revenue growth rate?
Longeveron LLC reported year-over-year revenue growth of -39.5% in its most recent quarter, with EPS growing +18.5% year-over-year.